Cost effectiveness of hepatitis C direct acting agents

By sjmartinez • April 26, 2024

Shetty A, Lee M, Valenzuela J, Saab S. Cost effectiveness of hepatitis C direct acting agents. Expert Rev Pharmacoecon Outcomes Res. 2024 Apr 26. doi: 10.1080/14737167.2024.2348053. Epub ahead of print. PMID: 38665122.

Tags: Antiviral Therapy, Cost effectiveness, Digestive Diseases, Direct acting agents, Hepatitis C, Publications

Associations of colonic transit with the gut microbiota and short-chain fatty acids in health and irritable bowel syndrome

Gao X, Dong Q, Shin AS. Associations of colonic transit with the gut microbiota and short-chain fatty acids in health and irritable bowel syndrome. Front[...]

Aggregatibacter aphrophilus Bacteremia Associated with Systemic Hemangiomatosis in an Elderly Patient with Ulcerative Colitis: A Case Report

Hendrie AG, Pabby V. Aggregatibacter aphrophilusBacteremia Associated with Systemic Hemangiomatosis in an Elderly Patient with Ulcerative Colitis: A Case Report. Case Rep Gastroenterol. 2026 Oct 1;20(1):417-429.[...]

Explicit and Implicit Biases Among Health Care Workers Caring for Patients With Chronic Liver Diseases

Lee TH, Kyalwazi B, Chai W, Rich N, Singal AG, Kanwal F; Liver Investigation of Variability in End-stage Results (LIVER) Research Group. Explicit and Implicit[...]